Analytic and clinical validation of a negative prediction algorithm for actionable mutations utilizing genomic and epigenomic profiling in cfDNA. Sintilimab plus bevacizumab, oxaliplatin, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results